🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
Patients with malignant pleural mesothelioma stage I-III who have undergone...
Status
Completed
Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Start Date
2019-02-04
Trial ID
NCT04177953
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in...
Status
Active Not Recruiting
Location
Mayo Clinic- Florida
Start Date
2017-09-12
Trial ID
NCT03241186
Treatments Being Tested
The purpose of this study is to describe real-world safety outcomes in chil...
Status
Completed
Location
Cardinal Health
Start Date
2023-08-14
Trial ID
NCT06163170
Treatments Being Tested
The purpose of this observational study is to describe the patient, disease...
Status
Completed
Location
Bayshore Specialty Rx Ltd.
Start Date
2023-09-05
Trial ID
NCT06361563
Treatments Being Tested
The purpose of this study is to evaluate the switch from Nivolumab Intraven...
Status
Withdrawn
Location
Local Institution - 0020
Start Date
2023-05-31
Trial ID
NCT05496192
Treatments Being Tested
This research study is studying the drugs called NeoVax (a new type of pers...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2022-01-03
Trial ID
NCT04930783
Treatments Being Tested
DONIMI is a phase 1b trial testing the combination of domatinostat + nivolu...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2020-01-07
Trial ID
NCT04133948
Treatments Being Tested